Here are the Form 4 insider transactions from PAVmed Inc. (PAVM) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PAVM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PAVM filings page.
Lee Victoria Tou-ho reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. reported that Chief Medical Officer Lee Victoria Tou-ho received a grant of 70,000 shares of common stock as an equity award. The restricted stock was granted at $0.00 per share and increases her direct holdings to 71,666 shares.
The award consists of restricted stock under PAVmed’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan and has a single vesting date of May 20, 2029. The shares are subject to forfeiture if the required service period is not completed, tying the grant to long-term employment and performance.
Aklog Lishan reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. Chairman and CEO Lishan Aklog received a grant of 350,000 shares of restricted common stock, awarded at $0.00 per share as equity compensation. The restricted stock was granted under PAVmed's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan and has a single vesting date of May 20, 2029. The award is subject to forfeiture if the required service period is not completed, tying the grant to long-term leadership retention. Following this grant, Dr. Aklog directly holds 357,614 shares of common stock, with additional indirect interests reported through family members and investment entities.
MCGRATH DENNIS M reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. reported that President and CFO Dennis M. McGrath received a grant of 180,000 shares of restricted common stock on April 2, 2026. The award was made under the company’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan.
The restricted stock carries a single vesting date of May 20, 2029 and is subject to forfeiture if the required service period is not completed. Following this grant, McGrath directly holds 186,695 shares of PAVmed common stock.
Glennon Michael J reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. director Michael J. Glennon reported an award of 13,930 shares of restricted common stock as equity compensation. The shares were granted at no cash cost to him under the company’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan and have a single vesting date of May 20, 2029. The restricted stock is subject to forfeiture if he does not complete the required service period. Following this grant, Glennon directly holds 21,653 shares of PAVmed common stock.
Baxter Timothy E reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. director Timothy E. Baxter received a grant of 13,930 shares of restricted common stock as equity compensation. These shares vest on May 20, 2029 and may be forfeited if he does not complete the required service period. Following this award, he directly holds 21,097 common shares.
White Debra reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. director Debra White received a grant of 13,930 shares of restricted common stock as compensation. The award was granted at $0.00 per share under the company’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan and has a single vesting date of May 20, 2029. The shares are subject to forfeiture if the required service period is not completed. Following this grant, White directly holds 21,097 shares of PAVmed common stock.
Sparks Ronald M reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. director Ronald M. Sparks received a grant of 13,930 shares of common stock as restricted stock under the company’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan. The award has a single vesting date of May 20, 2029 and is subject to forfeiture if the required service period is not completed. Following this grant, Sparks directly holds 21,097 shares of PAVmed common stock.
Agrawal Sundeep reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. director Sundeep Agrawal received a grant of 13,930 shares of restricted Common Stock as equity compensation. The award was granted at no cash purchase price and increases his direct holdings to 19,337 shares after the transaction.
The restricted stock was issued under PAVmed’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan and has a single vesting date of May 20, 2029. The shares are subject to forfeiture if he does not complete the required service period, tying the award to long-term board service.
Gordon Michael Adam reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. granted its General Counsel, Michael Adam Gordon, 110,000 shares of restricted common stock as equity compensation. The shares were granted at no cash cost and bring his direct holdings to 115,000 shares. The award vests on May 20, 2029 and is subject to forfeiture if he does not complete the required service period, making this a long-term retention incentive rather than an open-market purchase.
O'Neil Shaun reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. Chief Operating Officer Shaun O'Neil received a grant of 110,000 shares of common stock as restricted stock under the company's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan. The award has a single vesting date of May 20, 2029 and is subject to forfeiture if the required service period is not completed. Following this grant, O'Neil directly holds 115,598 shares of PAVmed common stock.